← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2020-01-10

Drug application

FDA Application #

ANDA212280

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

PREGABALIN CAPSULES, CV

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2020-01-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown